Cargando…
Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review
INTRODUCTION: The progression of complications of type 2 diabetes (T2D) is unique to each patient and can be depicted through individual temporal trajectories. Latent growth modeling approaches (latent growth mixture models [LGMM] or latent class growth analysis [LCGA]) can be used to classify simil...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508412/ https://www.ncbi.nlm.nih.gov/pubmed/36164545 http://dx.doi.org/10.1016/j.heliyon.2022.e10493 |
_version_ | 1784797012682604544 |
---|---|
author | O'Connor, Sarah Blais, Claudia Mésidor, Miceline Talbot, Denis Poirier, Paul Leclerc, Jacinthe |
author_facet | O'Connor, Sarah Blais, Claudia Mésidor, Miceline Talbot, Denis Poirier, Paul Leclerc, Jacinthe |
author_sort | O'Connor, Sarah |
collection | PubMed |
description | INTRODUCTION: The progression of complications of type 2 diabetes (T2D) is unique to each patient and can be depicted through individual temporal trajectories. Latent growth modeling approaches (latent growth mixture models [LGMM] or latent class growth analysis [LCGA]) can be used to classify similar individual trajectories in a priori non-observed groups (latent groups), sharing common characteristics. Although increasingly used in the field of T2D, many questions remain regarding the utilization of these methods. OBJECTIVE: To review the literature of longitudinal studies using latent growth modeling approaches to study T2D. METHODS: MEDLINE (Ovid), EMBASE, CINAHL and Wb of Science were searched through August 25(th), 2021. Data was collected on the type of latent growth modeling approaches (LGMM or LCGA), characteristics of studies and quality of reporting using the GRoLTS-Checklist and presented as frequencies. RESULTS: From the 4,694 citations screened, a total of 38 studies were included. The studies were published beetween 2011 and 2021 and the length of follow-up ranged from 8 weeks to 14 years. Six studies used LGMM, while 32 studies used LCGA. The fields of research varied from clinical research, psychological science, healthcare utilization research and drug usage/pharmaco-epidemiology. Data sources included primary data (clinical trials, prospective/retrospective cohorts, surveys), or secondary data (health records/registries, medico-administrative). Fifty percent of studies evaluated trajectory groups as exposures for a subsequent clinical outcome, while 24% used predictive models of group membership and 5% used both. Regarding the quality of reporting, trajectory groups were adequately presented, however many studies failed to report important decisions made for the trajectory group identification. CONCLUSION: Although LCGA were preferred, the contexts of utilization were diverse and unrelated to the type of methods. We recommend future authors to clearly report the decisions made regarding trajectory groups identification. |
format | Online Article Text |
id | pubmed-9508412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95084122022-09-25 Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review O'Connor, Sarah Blais, Claudia Mésidor, Miceline Talbot, Denis Poirier, Paul Leclerc, Jacinthe Heliyon Review Article INTRODUCTION: The progression of complications of type 2 diabetes (T2D) is unique to each patient and can be depicted through individual temporal trajectories. Latent growth modeling approaches (latent growth mixture models [LGMM] or latent class growth analysis [LCGA]) can be used to classify similar individual trajectories in a priori non-observed groups (latent groups), sharing common characteristics. Although increasingly used in the field of T2D, many questions remain regarding the utilization of these methods. OBJECTIVE: To review the literature of longitudinal studies using latent growth modeling approaches to study T2D. METHODS: MEDLINE (Ovid), EMBASE, CINAHL and Wb of Science were searched through August 25(th), 2021. Data was collected on the type of latent growth modeling approaches (LGMM or LCGA), characteristics of studies and quality of reporting using the GRoLTS-Checklist and presented as frequencies. RESULTS: From the 4,694 citations screened, a total of 38 studies were included. The studies were published beetween 2011 and 2021 and the length of follow-up ranged from 8 weeks to 14 years. Six studies used LGMM, while 32 studies used LCGA. The fields of research varied from clinical research, psychological science, healthcare utilization research and drug usage/pharmaco-epidemiology. Data sources included primary data (clinical trials, prospective/retrospective cohorts, surveys), or secondary data (health records/registries, medico-administrative). Fifty percent of studies evaluated trajectory groups as exposures for a subsequent clinical outcome, while 24% used predictive models of group membership and 5% used both. Regarding the quality of reporting, trajectory groups were adequately presented, however many studies failed to report important decisions made for the trajectory group identification. CONCLUSION: Although LCGA were preferred, the contexts of utilization were diverse and unrelated to the type of methods. We recommend future authors to clearly report the decisions made regarding trajectory groups identification. Elsevier 2022-09-13 /pmc/articles/PMC9508412/ /pubmed/36164545 http://dx.doi.org/10.1016/j.heliyon.2022.e10493 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article O'Connor, Sarah Blais, Claudia Mésidor, Miceline Talbot, Denis Poirier, Paul Leclerc, Jacinthe Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review |
title | Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review |
title_full | Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review |
title_fullStr | Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review |
title_full_unstemmed | Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review |
title_short | Great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: A literature review |
title_sort | great diversity in the utilization and reporting of latent growth modeling approaches in type 2 diabetes: a literature review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508412/ https://www.ncbi.nlm.nih.gov/pubmed/36164545 http://dx.doi.org/10.1016/j.heliyon.2022.e10493 |
work_keys_str_mv | AT oconnorsarah greatdiversityintheutilizationandreportingoflatentgrowthmodelingapproachesintype2diabetesaliteraturereview AT blaisclaudia greatdiversityintheutilizationandreportingoflatentgrowthmodelingapproachesintype2diabetesaliteraturereview AT mesidormiceline greatdiversityintheutilizationandreportingoflatentgrowthmodelingapproachesintype2diabetesaliteraturereview AT talbotdenis greatdiversityintheutilizationandreportingoflatentgrowthmodelingapproachesintype2diabetesaliteraturereview AT poirierpaul greatdiversityintheutilizationandreportingoflatentgrowthmodelingapproachesintype2diabetesaliteraturereview AT leclercjacinthe greatdiversityintheutilizationandreportingoflatentgrowthmodelingapproachesintype2diabetesaliteraturereview |